SCM adds vial filling capacity

- Last updated on GMT

SCM adds vial filling capacity
UK CDMO SCM Pharma is expanding its vial filling capacity to keep up with new clinical trial supply and commercial manufacturing contracts.

SCM - which has invested £500,000 (€595,710) in an automated vial filler - said “demand for liquid and powder filling from new clients and existing clients with scale-up requirements,​” citing BrePCO Pharma which contracted the production of trial batches of a candidate hypotension drug last month as driver​.

The new equipment – which is due to be operational this summer – will be capable of commercial-scale production runs, however, the main focus will still be smaller specialist projects according to SCM.

Although the investment will be a step change in the CDMO’s current filling capabilities, it remains at a scale that will be of interest mainly to companies requiring products for clinical trials and the supply of licensed drugs needed in niche markets such as orphan drugs​.”

Related news

Show more

Related product

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Related suppliers